Aktie A2AGV5 WAI YUEN TONG MEDICINE HOLDINGS LIMITED
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Wai Yuen Tong Medicine Holdings Limited

Aktien

A2AGV5

BMG9421Y2332

897

Markt geschlossen - Hong Kong S.E.
Andere Börsenplätze
 10:08:20 26.04.2024 		% 5 Tage % 1. Jan.
0,23 HKD 0,00 % Intraday Chart für Wai Yuen Tong Medicine Holdings Limited -5,35 % -42,50 %
02.04. Wai Yuen Tong Medicine Holdings Limited (SEHK:897) beginnt einen Aktienrückkaufplan für 117.110.288 Aktien, was 10% des ausgegebenen Aktienkapitals entspricht, im Rahmen der am 22. August 2023 erteilten Genehmigung. CI
28.03. Wai Yuen Tong Medicine Holdings Limited kündigt Wechsel des Gesellschaftssekretärs mit Wirkung zum 1. April 2024 an CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Wai Yuen Tong Medicine Holdings Limited commences an Equity Buyback Plan for 117,110,288 shares, representing 10% of its issued share capital, under the authorization approved on August 22, 2023.
Wai Yuen Tong Medicine Holdings Limited Announces Changes of Company Secretary, with Effect from 1 April 2024
Wai Yuen Tong Medicine Unit to Sell Properties in Hong Kong
Wai Yuen Tong Medicine Plans Special Dividend of Wang On, China Agri-Products Shares; Shares Up 7%
Wai Yuen Tong Medicine Holdings Limited agreed to Spin-Off Wang On Group Limited.
Wai Yuen Tong to Buy Shop Space in Hong Kong
Wai Yuen Tong Medicine Shareholders to Vote Jan. 30 on Granting of Loan Facility to Wang On
Tranche Update on Wai Yuen Tong Medicine Holdings Limited's Equity Buyback Plan announced on September 1, 2022.
Wai Yuen Tong Medicine to Extend Revolving Loan Facility to Wang On
Wai Yuen Tong Medicine Holdings Limited Announces Change of Independent Non-Executive Directors and Change in Compositions of Board Committees
Wai Yuen Tong Medicine Returns to Profit in Fiscal H1
Wai Yuen Tong Medicine Holdings Limited Reports Earnings Results for the Half Year Ended September 30, 2023
Wai Yuen Tong Medicine Subsidiary Sells Stake in Owner of Leased Shops
Wai Yuen Tong Medicine to Return to Profit in Fiscal H1
Wai Yuen Tong Medicine Holdings Limited Provides Consolidated Earnings Guidance for the Six Months Ended 30 September 2023
Wai Yuen Tong Medicine Holdings Limited's Equity Buyback announced on September 1, 2022, has expired with 60,540,000 shares, representing 4.98% for HKD 24.69 million.
Wai Yuen Tong Medicines' Fiscal Year 2023 Loss Narrows
Tranche Update on Wai Yuen Tong Medicine Holdings Limited's Equity Buyback Plan announced on September 1, 2022.
Wai Yuen Tong Medicine Holdings Limited Reports Earnings Results for the Full Year Ended March 31, 2023
Wai Yuen Tong Medicine to Narrow Full-Year Loss
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A2AGV5 Aktie
  4. Nachrichten Wai Yuen Tong Medicine Holdings Limited
  5. Andere Sprachen